Hanmi Pharm. Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Other Revenue	-	-	-	-0	-	-0	Upgrade
Revenue	1,495,700	1,495,502	1,490,887	1,331,547	1,203,186	1,075,854	Upgrade
Revenue Growth (YoY)	-4.50%	0.31%	11.97%	10.67%	11.83%	-3.39%	Upgrade
Cost of Revenue	671,900	678,465	661,638	612,994	570,433	494,935	Upgrade
Gross Profit	823,800	817,037	829,249	718,553	632,752	580,918	Upgrade
Selling, General & Admin	417,600	421,960	426,789	406,146	361,309	319,555	Upgrade
Research & Development	-	178,891	181,769	154,317	146,027	212,387	Upgrade
Other Operating Expenses	177,900	-	-	-	-	-	Upgrade
Operating Expenses	595,500	604,526	604,364	564,657	507,336	531,942	Upgrade
Operating Income	228,300	212,511	224,885	153,896	125,416	48,976	Upgrade
Interest Expense	-	-24,374	-28,508	-22,647	-16,577	-24,867	Upgrade
Interest & Investment Income	-	5,666	4,618	7,856	5,722	4,380	Upgrade
Earnings From Equity Investments	-	-9.2	1,258	-8,537	-4.02	-	Upgrade
Currency Exchange Gain (Loss)	-	9,318	1,039	-2,641	13.07	3,461	Upgrade
Other Non Operating Income (Expenses)	-43,100	-29,309	-4,571	-3,620	-9,277	-5,462	Upgrade
EBT Excluding Unusual Items	185,200	173,802	198,721	124,308	105,293	26,488	Upgrade
Gain (Loss) on Sale of Investments	-	-87.92	2,630	47.09	-	-4,514	Upgrade
Gain (Loss) on Sale of Assets	-	27.74	1,769	451.65	-1,062	-313.72	Upgrade
Asset Writedown	-	-2,488	-9,153	-3,794	-535.2	470.68	Upgrade
Pretax Income	185,200	171,254	193,967	121,013	103,697	22,130	Upgrade
Income Tax Expense	31,300	30,823	28,601	19,454	22,218	4,841	Upgrade
Earnings From Continuing Operations	153,900	140,431	165,366	101,558	81,478	17,290	Upgrade
Minority Interest in Earnings	-	-19,116	-19,135	-18,766	-14,453	-5,330	Upgrade
Net Income	153,900	121,315	146,231	82,792	67,025	11,959	Upgrade
Net Income to Common	153,900	121,315	146,231	82,792	67,025	11,959	Upgrade
Net Income Growth	-4.21%	-17.04%	76.63%	23.52%	460.45%	-77.05%	Upgrade
Shares Outstanding (Basic)	13	13	13	13	13	13	Upgrade
Shares Outstanding (Diluted)	13	13	13	13	13	13	Upgrade
Shares Change (YoY)	-0.03%	-0.08%	-0.09%	-0.12%	-0.11%	-0.09%	Upgrade
EPS (Basic)	10387.45	9566.83	11522.12	6517.33	5269.87	939.25	Upgrade
EPS (Diluted)	10387.45	9566.83	11522.12	6517.33	5269.87	939.25	Upgrade
EPS Growth	-18.00%	-16.97%	76.79%	23.67%	461.07%	-77.03%	Upgrade
Free Cash Flow	-	154,226	189,186	131,890	181,974	109,719	Upgrade
Free Cash Flow Per Share	-	12162.13	14906.67	10382.37	14307.73	8617.07	Upgrade
Dividend Per Share	1000.000	1250.000	-	-	-	-	Upgrade
Gross Margin	55.08%	54.63%	55.62%	53.96%	52.59%	54.00%	Upgrade
Operating Margin	15.26%	14.21%	15.08%	11.56%	10.42%	4.55%	Upgrade
Profit Margin	10.29%	8.11%	9.81%	6.22%	5.57%	1.11%	Upgrade
Free Cash Flow Margin	-	10.31%	12.69%	9.90%	15.12%	10.20%	Upgrade
EBITDA	-	309,842	323,339	250,738	214,502	110,315	Upgrade
EBITDA Margin	-	20.72%	21.69%	18.83%	17.83%	10.25%	Upgrade
D&A For EBITDA	97,806	97,331	98,454	96,842	89,086	61,339	Upgrade
EBIT	228,300	212,511	224,885	153,896	125,416	48,976	Upgrade
EBIT Margin	15.26%	14.21%	15.08%	11.56%	10.42%	4.55%	Upgrade
Effective Tax Rate	16.90%	18.00%	14.74%	16.08%	21.43%	21.87%	Upgrade
Advertising Expenses	-	78,789	76,034	72,627	62,201	58,772	Upgrade

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.